Back to Research Hub
Gilead Sciences, Inc.
GILD
$125.50-2.60 (-2.03%)
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
StreetsValue research for Gilead Sciences, Inc. (GILD)
Members get the full report for Gilead Sciences, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.